Mark K. Lafferty

419 citations
14 papers · 356 · h-index 9

Impact in

  • Virology top 5%
    • HIV Research and Treatment
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • interferon and immune responses
    • Immune Response and Inflammation

Papers in

    • HIV Research and Treatment 8
    • Immune Cell Function and Interaction 5
    • Immunotherapy and Immune Responses 3
    • T-cell and B-cell Immunology 3

Mark K. Lafferty

14 papers receiving 349 citations

Peers

Mark K. Lafferty
Comparison fields: 5 of 46
  • Virology 179
  • Immunology 169
  • Microbiology 48
  • Infectious Diseases 41
  • Oncology 53
Replace Rada Ellegård with:
Rada Ellegård Sweden
Troels Bygum Knudsen Denmark
Federico Perdomo-Celis Colombia
Louise E. Hogan United States
Rocío Bellido Spain
Jake W. Rhodes Australia
Yvonne B. Sullivan United States
Yuria Ablanedo‐Terrazas Mexico
J.M. Bourez France
I. Bourgault France
Mark K. Lafferty relative to Rada Ellegård Sweden Rada Ellegård's profile →
Citations per field
00.5×1.7×
Rada Ellegård · 1×
Citations per year

Countries citing papers authored by Mark K. Lafferty

Since Specialization
Citations

This map shows the geographic impact of Mark K. Lafferty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Lafferty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Lafferty more than expected).

Fields of papers citing papers by Mark K. Lafferty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark K. Lafferty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Lafferty. The network helps show where Mark K. Lafferty may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark K. Lafferty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark K. Lafferty Line = papers co-authored together Mark K. Lafferty links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 201077
2 201651
3 200947
4 201239
5 201630
6 201330
7 200929
8 201725
9 201515
10 20137
11 20063
12 20211
13 20131
14 20111

About Mark K. Lafferty

Mark K. Lafferty is a scholar working on Virology, Immunology, Pathology and Forensic Medicine, Oncology and Microbiology, having authored 14 papers that have together received 356 indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Antimicrobial Peptides and Activities (3 papers), Vascular Malformations and Hemangiomas (1 paper) and Bone Metabolism and Diseases (1 paper). The work is most often cited by research in Virology (179 citations), Immunology (169 citations), Microbiology (48 citations), Infectious Diseases (41 citations) and Oncology (53 citations). Mark K. Lafferty has collaborated with scholars based in United States, Italy and Nigeria. Frequent co-authors include Alfredo Garzino‐Demo, Lingling Sun, Wuyuan Lu, Luigi Marchionni, Aaron Christensen-Quick, Robert C. Gallo, Anthony L. DeVico, Joseph Bryant, Gerd Fätkenheuer and Pia Hartmann. Their work appears in journals such as Pathogens and Disease, Retrovirology, Proceedings of the National Academy of Sciences, Journal of Virology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact